Clls price
WebMar 20, 2024 · The average 12-month price objective among analysts that have issued a report on the stock in the last year is $9.71. CLLS has been the topic of a number of recent research reports.
Clls price
Did you know?
WebAccording to . 3 Wall Street analysts that have issued a 1 year CLLS price target, the average CLLS price target is $11.67, with the highest CLLS stock price forecast at $16.00 and the lowest CLLS stock price forecast at $6.00.On average, Wall Street analysts predict. that Cellectis Sa's share price could reach $11.67 by Apr 5, 2024. WebAverage analysts price target $37 Buy rating Cellectis SA is a biopharmaceutical company, which engages in the research and development of genome engineering technology. The …
WebApr 11, 2024 · Cellectis stock opened at $1.96 on Tuesday. The company’s 50-day moving average price is $2.18 and its 200-day moving average price is $2.37. The company has a quick ratio of 2.28, a current ... WebMar 10, 2024 · CLLS’s market cap is 110.62 Mil. Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used …
WebApr 6, 2024 · According to 10 analysts, the average rating for CLLS stock is "Buy." The 12-month stock price forecast is $23.95, which is an increase of 1,163.85% from the latest price. WebApr 6, 2024 · According to 10 analysts, the average rating for CLLS stock is "Buy." The 12-month stock price forecast is $14.95, which is an increase of 658.88% from the latest price.
WebHow much is Cellectis Sa stock worth today? ( NASDAQ: CLLS) Cellectis Sa currently has 45,565,810 outstanding shares. With Cellectis Sa stock trading at $2.16 per share, the total value of Cellectis Sa stock (market capitalization) is $98.42M. Cellectis Sa stock was originally listed at a price of $39.30 in Mar 25, 2015.
WebThe 11 analysts offering 12-month price forecasts for Cellectis SA have a median target of 7.00, with a high estimate of 24.00 and a low estimate of 2.00. The median estimate represents a +258.97% ... quotation jacketWeb22 hours ago · Price To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for Cellectis (CLLS) cwa 1180 participating dentistsWebFind real-time CLLS - Cellectis SA stock quotes, company profile, news and forecasts from CNN Business. ... Price/Sales: 4.99: Price/Book: 0.75: Competitors Today’s change … cwa conversion to gpaWebGet the latest Cellectis SA (CLLS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. quota\u0027s s5WebAccording to our current CLLS stock forecast, the value of Cellectis S.A. shares will rise by 5.17% and reach $ 2.05 per share by April 7, 2024. According to our technical indicators, the current sentiment is Bearish while the Fear & Greed Index is showing 39 (Fear).CLLS stock recorded 6/30 (20%) green days with 13.38% price volatility over the last 30 days. quotation jane austenWebThe Trend in the Analyst Price Target. Over the past 14 months, CLLS's average price target has gone down $9.7. Over the past 43 weeks, CLLS's average upside potential has been 476.04%. Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential; 2024-05-24: 7: 33: 2: 15.714: 3.62: … quotation maker apkWebApr 12, 2024 · More News & Analysis on CLLS. ... Cellectis price target lowered to $16 from $24 at Citi. CLLS. Cellectis enters into warrant agreement with the European Investment Bank related to credit facility agreement and announces the drawdown of the first tranche of €20 million. CLLS. cw2442r cabinet